SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,998,524 | -8.1% | 1,704,698 | +0.2% | 0.77% | -3.4% |
| Q2 2023 | $51,123,493 | -15.1% | 1,700,715 | +2.3% | 0.80% | -20.8% |
| Q1 2023 | $60,223,752 | +4.6% | 1,662,262 | +3.6% | 1.01% | -3.4% |
| Q4 2022 | $57,579,112 | +5.9% | 1,604,769 | -0.1% | 1.04% | +1.3% |
| Q3 2022 | $54,357,000 | +16.6% | 1,605,806 | -0.4% | 1.03% | +19.5% |
| Q2 2022 | $46,630,000 | -9.9% | 1,612,382 | +0.7% | 0.86% | +13.7% |
| Q1 2022 | $51,755,000 | +12.5% | 1,601,344 | +1.5% | 0.76% | +27.6% |
| Q4 2021 | $46,014,000 | +39.1% | 1,577,980 | +27.2% | 0.59% | +32.0% |
| Q3 2021 | $33,073,000 | -13.7% | 1,240,078 | -0.4% | 0.45% | -14.3% |
| Q2 2021 | $38,344,000 | +28.4% | 1,245,329 | +9.2% | 0.52% | +21.2% |
| Q1 2021 | $29,859,000 | +40.4% | 1,140,519 | +34.9% | 0.43% | +37.0% |
| Q4 2020 | $21,270,000 | +241.7% | 845,378 | +183.1% | 0.32% | +187.3% |
| Q3 2020 | $6,224,000 | -2.7% | 298,640 | +10.8% | 0.11% | -5.2% |
| Q2 2020 | $6,399,000 | +26.6% | 269,422 | -4.1% | 0.12% | -4.9% |
| Q1 2020 | $5,054,000 | -23.9% | 280,947 | +0.3% | 0.12% | -2.4% |
| Q4 2019 | $6,643,000 | -15.5% | 280,053 | -2.2% | 0.12% | -20.9% |
| Q3 2019 | $7,866,000 | -22.5% | 286,232 | -6.6% | 0.16% | -17.7% |
| Q2 2019 | $10,146,000 | +37.8% | 306,622 | +45.9% | 0.19% | +28.0% |
| Q1 2019 | $7,363,000 | +5.2% | 210,128 | -0.3% | 0.15% | -9.6% |
| Q4 2018 | $7,002,000 | -20.4% | 210,791 | +20.7% | 0.17% | +2.5% |
| Q3 2018 | $8,793,000 | -19.5% | 174,641 | -6.7% | 0.16% | -26.4% |
| Q2 2018 | $10,925,000 | +30.6% | 187,230 | +2.5% | 0.22% | +21.5% |
| Q1 2018 | $8,363,000 | +14.3% | 182,600 | -0.5% | 0.18% | +8.4% |
| Q4 2017 | $7,316,000 | – | 183,593 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |